Tag
Gland Pharma Limited
3 articles
Gland Pharma Q4 FY26 Revenue Up 22% YoY
Gland Pharma reported Q4 FY26 revenue of INR17,428 million, a 22% YoY growth, with adjusted EBITDA at INR5,244 million (30% margin).
Full-year FY26 revenue reached INR64,307 million (14.5% growth), wi
Gland Pharma Schedules May Investor Meetings
Gland Pharma intimated scheduled analyst and institutional investor meetings for May 2026 pursuant to SEBI LODR regulations.
Meetings include one-on-one sessions with Carnelian Asset Management and As
Gland Pharma Q4 FY26 Earnings Call Recording Uploaded
Gland Pharma uploaded the audio recording of its Q4 and FY26 earnings call held on May 15, 2026, to its website.
The disclosure was made pursuant to SEBI LODR Regulations 30 and 46, continuing from an